Founded in 2023, Benecyte, Inc. is a US company based in Durham, North Carolina, developing allogeneic cytokine-induced killer (CIK) cells for cancer immunotherapies and extending our platform to solid tumors.
| Website | https://www.benecyte.com |
| Employees | 36 (1 on RocketReach) |
| Address | 4233 Technology Dr, Durham, North Carolina 27704, US |
| Industry | Research |
| Keywords | Cancer Immunotherapy, Biopharma, Immunotherapy, Cell Therapy, Cancer Treatment, Oncology, Precision Medicine, Solid Tumor Treatment, Regenerative Medicine, Immuno-Oncology, Cancer Research, Biotechnology, Pharmaceutical, Clinical Trials, Drug Development, Healthcare |
| Competitors | Oracle, Veeva Systems, RWE GBS UK, TransPerfect, Medidata Solutions, Synarc, Ideagen, Medable, Inc, Clinical ink, Castor +33 more (view full list) |
Looking for a particular Benecyte, Inc. employee's phone or email?
1 people are employed at Benecyte, Inc..
Benecyte, Inc. is based in Durham, North Carolina.